Renaissance Technologies - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
-4.1%
44,300
+31.5%
0.00%
Q2 2023$121
+365.4%
33,700
+183.2%
0.00%
Q1 2023$26
-100.0%
11,900
-96.7%
0.00%
-100.0%
Q2 2022$1,647,000
-43.2%
359,697
+77.0%
0.00%
-50.0%
Q4 2021$2,902,000
+83.8%
203,200
-45.4%
0.00%
+100.0%
Q4 2020$1,579,000
+29.1%
372,415
-20.5%
0.00%
+100.0%
Q3 2020$1,223,000
+54.4%
468,615
+108.9%
0.00%0.0%
Q2 2020$792,000
+38.2%
224,315
+19.1%
0.00%0.0%
Q1 2020$573,000
-51.2%
188,415
-17.3%
0.00%0.0%
Q4 2019$1,173,000
+73.5%
227,725
+7.5%
0.00%0.0%
Q3 2019$676,000
+19.0%
211,925
+34.0%
0.00%0.0%
Q2 2019$568,000
+48.7%
158,098
+50.5%
0.00%
Q1 2019$382,000
+117.0%
105,055
+79.5%
0.00%
Q4 2018$176,000
-11.6%
58,528
+43.3%
0.00%
Q3 2018$199,000
-76.6%
40,845
-66.8%
0.00%
Q2 2018$849,000
+87.0%
122,900
+76.1%
0.00%
Q1 2018$454,000
-46.1%
69,800
-25.3%
0.00%
-100.0%
Q4 2017$842,000
+2.2%
93,500
+12.7%
0.00%0.0%
Q3 2017$824,000
+322.6%
83,000
+230.7%
0.00%
Q2 2017$195,00025,1000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders